Literature DB >> 25430397

Role of cortisol in patients at risk for psychosis mental state and psychopathological correlates: A systematic review.

Evangelos Karanikas1, Giorgos Garyfallos.   

Abstract

During recent decades, much evidence has been accumulated concerning the neuroendocrine basis of schizophrenia. Recently, research has focused on stress hormones, with cortisol being the most widely researched, during the prodromal phase of psychosis. Thus, the present study aims to systematically review the evidence concerning the role of cortisol in patients at risk for psychosis mental state and its associations with psychopathological correlates. We systematically reviewed the published reports referring to both 'at clinical risk for psychosis' and 'at genetic risk for psychosis' mental state. Sixteen studies were identified. A trend towards increased cortisol levels in saliva emerged. Findings concerning cortisol levels in the blood were minimal and less consistent. The longitudinal studies, though with divergent results, hinted towards upregulation of cortisol secretion prior to psychotic conversion. Regarding cortisol's reactivity, evaluated through neuroendocrine, psychosocial and naturalistic stressors, the findings were minimal and divergent. The hypothesized relation of psychotic symptomatology with cortisol in subjects at risk for psychosis was not confirmed by the majority of the studies. On the contrary, the anxiety parameter and stress-intolerance index were both positively associated with cortisol. In conclusion, the published reports related to the evaluation of cortisol levels/function at prodrome are hitherto minimal. Although the evidence favors cortisol's participation in the pathophysiology of psychosis, the exact cause-effect sequence and the intertwining of cortisol with psychopathology are still unclear.
© 2014 The Authors. Psychiatry and Clinical Neurosciences © 2014 Japanese Society of Psychiatry and Neurology.

Entities:  

Keywords:  cortisol; hypothalamo-pituitary-adrenal axis; psychopathology; psychosis; risk

Mesh:

Substances:

Year:  2015        PMID: 25430397     DOI: 10.1111/pcn.12259

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN: 1323-1316            Impact factor:   5.188


  13 in total

1.  The Fragile Brain: Stress Vulnerability, Negative Affect and GABAergic Neurocircuits in Psychosis.

Authors:  Stephan F Taylor; Tyler B Grove; Vicki L Ellingrod; Ivy F Tso
Journal:  Schizophr Bull       Date:  2019-10-24       Impact factor: 9.306

2.  Vitamin D deficiency, behavioral atypicality, anxiety and depression in children with chromosome 22q11.2 deletion syndrome.

Authors:  L Kelley; A F P Sanders; E A Beaton
Journal:  J Dev Orig Health Dis       Date:  2016-12       Impact factor: 2.401

3.  The relationship between cannabis use and cortisol levels in youth at ultra high-risk for psychosis.

Authors:  Emily E Carol; Robert L Spencer; Vijay A Mittal
Journal:  Psychoneuroendocrinology       Date:  2017-05-30       Impact factor: 4.905

4.  Resting cortisol level, self-concept, and putative familial environment in adolescents at ultra high-risk for psychotic disorders.

Authors:  Emily E Carol; Vijay A Mittal
Journal:  Psychoneuroendocrinology       Date:  2015-03-28       Impact factor: 4.905

5.  Associations between physiological responses to social-evaluative stress and daily functioning in first-episode schizophrenia.

Authors:  Alexandra C Reed; Junghee Lee; Michael F Green; Holly K Hamilton; Gregory A Miller; Kenneth L Subotnik; Joseph Ventura; Keith H Nuechterlein; Cindy M Yee
Journal:  Schizophr Res       Date:  2020-01-14       Impact factor: 4.939

6.  Sex differences in morning cortisol in youth at ultra-high-risk for psychosis.

Authors:  Emily E Carol; Robert L Spencer; Vijay A Mittal
Journal:  Psychoneuroendocrinology       Date:  2016-06-21       Impact factor: 4.905

Review 7.  Overlapping Neurobiological Substrates for Early-Life Stress and Resilience to Psychosis.

Authors:  Pamela DeRosse; Anita D Barber
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2020-09-10

8.  Pituitary volume reduction in schizophrenia following cognitive behavioural therapy.

Authors:  Preethi Premkumar; Danielle Bream; Adegboyega Sapara; Dominic Fannon; Anantha P Anilkumar; Elizabeth Kuipers; Veena Kumari
Journal:  Schizophr Res       Date:  2017-04-21       Impact factor: 4.939

Review 9.  Inflammation, Stress Response, and Redox Dysregulation Biomarkers: Clinical Outcomes and Pharmacological Implications for Psychosis.

Authors:  Stefania Schiavone; Luigia Trabace
Journal:  Front Psychiatry       Date:  2017-10-25       Impact factor: 4.157

10.  A variant in the 3'-untranslated region of the MC2R gene decreases the risk of schizophrenia in a female Han Chinese population.

Authors:  Liang Tang; Qin Xiang; Ju Xiang; Jianming Li; Danna Chen
Journal:  J Int Med Res       Date:  2021-07       Impact factor: 1.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.